Asia Pacific Veterinary Vaccines Market Size, Share, and Analysis by 2028

The APAC veterinary vaccines market is expected to grow from US$ 2,257.78 million in 2021 to US$ 3,677.55 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028.

The veterinary care business is witnessing substantial transformations. Countries across the region have favored sophisticated remedies and supplements that are simple to use and beneficial in healthcare. Countries across the region are projected to be among the biggest contributors to this expansion in veterinary healthcare. The increasing rate of pet ownership, rising disposable income of the population, and growing awareness related to pet health are among the factors that are likely to drive the growth of the market in the future. Further, improvement in animal welfare across the countries and implementation of rules for the manufacturing of animal vaccines and nutritional supplements would propel the growth of the market in emerging countries in the coming years. There has been a movement in the business approach of animal health enterprises that have grown from medicines to preventive to productivity enhancement and now to total healthcare of the animals. This is expected to increase the adoption of veterinary vaccines in the potential market and several countries, which is projected to create lucrative opportunities for APAC market growth during the forecast period.      

In case of COVID-19, APAC is highly affected specially India. The impact of pandemic is far-reaching. Asian economies were among the earliest epicenters of the pandemic, but also considered to be more effective in controlling the spread of the virus. Powerful economies such as Japan, and South Korea felt the disruption that the pandemic has caused. Covid-19 have emerged as a challenge in the market of veterinary vaccines, it reduced the intensity of various veterinary activities across the globe. However, companies were focused on making animal health vaccines, drugs, and equipment more accessible to consumers by fortifying their supply chains and promoting these products as essential goods, which can be an interlude for the veterinary vaccines market overall. A revolutionized change occurred in the veterinary vaccines market due to the impact of the virus. The complete lockdown in various countries forbidden the transportation of raw materials and forbade service providers’ business. Due to which the operations of various companies failed; however, few companies managed to be afloat. For Instance: Even during the pandemic Virbac ensured the best possible continuity of commitments to veterinarians, farmers, and animal owners who, every day on the front line, continued their essential work to care for and raise those animals. Therefore, manufacturing of these vaccines became difficult to an extent, which directly impacted the APAC veterinary vaccines market. 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC veterinary vaccines market. The APAC veterinary vaccines market is expected to grow at a good CAGR during the forecast period. 

APAC Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)    

APAC Veterinary Vaccines Market Segmentation 

APAC Veterinary Vaccines Market – By Vaccine Type

• Livestock Vaccines
  • Bovine Vaccines
  • Small Ruminant Vaccines
• Companion Animal Vaccines
  • Feline Vaccines
  • Canine Vaccines
  • Others
• Others

APAC Veterinary Vaccines Market – By Technology

• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines 
• Conjugate Vaccines
• Others

APAC Veterinary Vaccines Market, by Country

• China
• Japan  
• India
• Australia
• South Korea
• Rest of APAC

APAC Veterinary Vaccines Market - Companies Mentioned

• BIOVAC
• Boehringer Ingelheim International GmbH
• Ceva
• Elanco
• Hester Biosciences Limited
• HIPRA
• Merck & Co., Inc. 
• NEOGEN Corporation
• Virbac
• Zoetis Inc.

Asia Pacific Veterinary Vaccines Report Scope